Advertisement

Topics

Companies Related to "Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery" [Most Relevant Company Matches] RSS

21:46 EST 16th December 2018 | BioPortfolio

Here are the most relevant search results for "Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery" found in our extensive corporate database of over 50,000 company records.

Showing "Doxorubicin Interleukin Treating Patients With Liver Cancer That" Companies 1–25 of 5,700+

Extremely Relevant

FeRx Incorporated

The Company is focused on the development and commercialization of its proprietary Magnetic Targeted Carrier ("MTC") technology for the site specific delivery and sustained release of pharmaceutical agents. FeRx's lead compound, MTC-Doxorubicin, is in Phase I/II clinical trials in patients with liver cancer.


Relevant

YES

YES is a grassroots organization that provides cancer patients with support, resources, options, education and hope in their fight against liver tumors. It is made up of survivors who have undergone treatment for primary hepatocellular (liver) cancer or liver metastases (cancer that has spread to the liver) from other cancers. For more information ...

The Pelican Cancer Foundation

The Pelican Cancer Foundation is a unique charity, dedicated exclusively to curing cancer patients by advancing the latest techniques of precision surgery.The Charity derives its name from the words Pelvic and Liver Cancer.Formed in 2000, it was based around the pioneering work ofProfessor ‘Bill’ Heald OBE, Mr Brendan Moran and colleagues at the North Hampshire Hospital in bowel cancer surgery...


Sirtex Medical Inc.

Sirtex Medical Limited (ASX:SRX) is an Australian-based global healthcare business working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. More than 50,000 doses have been supplied to treat patients with liver cancer at more than 800 medical...

Genetronics Biomedical

Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk, breathe, or swallow. Genetronics received approval from the U.S. Food and Drug Administration and initiated Phase II multi-center clinical trials at nine sites in the U.S. The trials test the effectiv...

Arbios Systems, Inc.

Arbios Systems, Inc. is developing proprietary medical devices and cell-based therapies to enhance the survival of millions of patients each year who experience, or are at risk for, life-threatening episodes of liver failure. The Arbios product candidate portfolio includes the SEPET™ Liver Assist Device, a novel blood purification therapy that provides enhanced “liver dialysis,” and the H...

Corporate Communications, CEL-SCI Corporation

CEL-SCI Corporation (AMEX: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of drugs and vaccines for the treatment of cancer and infectious diseases. The Company’s core capabilities include drug discovery, research, development and manufacturing of complex biological substances.Recurrence of cancer is the greatest fear for the cancer patient...

Vicus Therapeutics, LLC

Vicus Therapeutics is a biopharmaceutical company dedicated to bringing breakthrough therapies to patients with cancer. Vicus' lead investigational therapy, VT-122, is a combination of etodolac and propranolol. VT-122 showed positive results in a Phase 2 clinical trial of lung cancer patients and is currently being evaluated in a Phase 2 clinical trial of liver cancer patients receiving Nexavar ...

Celsion

Founded in 1982, with a vision of using heat to kill cancer and treat other diseases, Celsion began trading publicly in 1985 under the name Cheung Laboratories, Inc. The early research focus of the Company was device oriented heat-based treatment systems. The Company was renamed Celsion Corporation and listed on the American Stock Exchange under the symbol CLN, in the mid 1990's. At that time, Cel...

Globe Laboratories

Globe Labs manufactures and sells high quality, low cost human therapeutic proteins, human growth hormones, enzymes, research laboratory cytokines, chemokines & their respective inhibitors/antagonists for research and veterinary use. We are also manufacturers of bulk quantities for other pharmaceutical companies worldwide. Globe Labs is proud to have the largest antagonist product list in the worl...

American Liver Foundation

The American Liver Foundation is the nation’s largest non-profit organization focused solely on promoting liver health and disease prevention. The mission of the American Liver Foundation is to facilitate, advocate and promote education, support and research for the prevention, treatment and cure of liver disease.

Cancer Vaccines Ltd

Cancer Vaccines Ltd is a biopharmaceutical company focused on the development and commercialisation of safe and effective therapeutic vaccines for the treatment of cancer. The company was founded in 1999 and won a DTI SMART Award.The attraction of a vaccination based approach to treating cancer is widely acknowledged, and many researchers and clinicians have worked in this area. Historically the a...

Cancer Therapeutics, Inc.TM

Founded in 1991, Cancer Therapeutics, Inc.TM (CTI) is a biotherapy company that is a leader in activated cell technology for cancer therapy. CTI's laboratory offers access to technologies grouped under the modality of Biotherapy. Biotherapy is based on treatments that enhance the patient's own immune system to attack the invading cancer. Research has shown cancer to be a highly individualized dise...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its resear...

Delcath Systems

Our objective is to establish the use of the Delcath system as the standard technique for delivering chemotherapy agents to the liver and to expand the Delcath technology so that it may be used in the treatment of other liver diseases and of cancers in other parts of the body. Our strategy includes the following: Complete clinical trials to obtain FDA approval for the Delcath system with doxorubi...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intell...

Brooklyn ImmunoTherapeutics LLC

Brooklyn ImmunoTherapeutics (formerly IRX Therapeutics) is focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies.

PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...

Targeted Diagnostics and Therapeutics

TDT has emerged as a leader in the development of innovative molecular diagnostics and therapeutics that can improve the quality of life of patients with colorectal cancer and gastrointestinal malignancies. Focused on innovative research and cutting edge technology, TDT has developed highly specific tests to detect colorectal cancer cells in lymph nodes from patients who have undergone surgical st...

ORIDIS Biomed GmbH

ORIDIS™ Biomed is a biomedical company focusing on the discovery and development of therapeutics and targeted treatment solutions for liver cancer and metabolic diseases of the liver.ORIDIS™ Biomed has built a potent drug discovery and development organization based on its extensive scientific and clinical expertise in the area of liver disease, its proprietary TISSOMICS™ research engine, an...

Galectin Therapeutics, Inc.

Galectin Therapeutics (OTC: GALT) is developing promising carbohydrate-based therapies for fibrotic liver disease and cancer based on the Company’s unique understanding of galectin proteins, key mediators of biologic function. We are leveraging extensive scientific and development expertise as well as established relationships with external sources to...

Vesta Therapeutics, Inc

Vesta Therapeutics is a privately held company developing cell therapeutics for liver repair and regeneration. The Company's technology is centered on the isolation, expansion, and cryopreservation of liver cells (human hepatocytes) obtained from organ donor livers that are not suitable for whole organ transplantation. Clinicians in academic settings have found that, following administration, huma...

Ambys Medicines

Ambys Medicines is a biotechnology company focused on discovering and developing transformative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet th...

Jennerex Biotherapeutics

Jennerex is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594, currently in an international randomized Phase 2 clinical trial for patients with primary liver cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse a...

Navigating Cancer

Navigating Cancer is dedicated to empowering cancer patients to navigate their best care. Navigating Cancer, www.navigatingcancer.com, is a free web application that offers personalized tools and authoritative cancer resources to help patients take control of their health and partner more closely with their physicians, support network and other like patien...


More From BioPortfolio on "Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks